Volume 7, Issue 11 , Pages 1156-1163, November 2009
Evidence for Endoscopic Ulcers as Meaningful Surrogate Endpoint for Clinically Significant Upper Gastrointestinal Harm
Full Text Available
Conflicts of interest The authors disclose the following: All the authors have received research grants, consulting, or lecture fees from pharmaceutical companies, charities, and government sources at various times. The authors were involved in discussions concerning a review, supported by Pfizer Inc, for the creation of a white paper for presentation to regulatory authorities. The decision to write this paper was the decision of the authors. Pfizer and its agents had no role in the interpretation of data or writing of the paper, or in the decision to publish. The authors had the absolute right to publish the results of their research regardless of any conclusions reached. No payments were received for preparing this manuscript.
PII: S1542-3565(09)00316-4
doi:10.1016/j.cgh.2009.03.032
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Endoscopic Ulcers Are Neither Meaningful Nor Validated as a Surrogate for Clinically Significant Upper Gastrointestinal Harm , 26 June 2009
Volume 7, Issue 11 , Pages 1156-1163, November 2009


